Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Jnj crawled date : 2022 - 02 - 28 save search
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
TAK | News | $13.26 -0.9% 210K
|
Health Technology
|
| O: 0.54%
H: 1.66%
C: 1.13%
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
ARCT 4 | $28.09 0.57% 42K
|
Health Technology
|
| O: -0.93%
H: 3.16%
C: 2.35%
ces therapeutics
Bavarian Nordic to Host Full Year 2021 Results Conference Call
Published: 2022-02-28 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
conference results
Warm Autoimmune Hemolytic Anemia Market is Expected to Witness Growth at an Accelerated CAGR of 14.7% in the 7MM for the Study Period 2018-30, Assesses DelveInsight
Published: 2022-02-28 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
INCY | $51.44 -0.41% 97K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
anemia cel growth
Pause of GSK's RSV Vaccine Trials in Pregnant Women Deepens
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
als trials trial women vaccine
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Atopic Dermatitis
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
lnk0100 als atopic dermatitis ces dermatitis derm 100
Proud to support the EcoBeautyScore Consortium
Published: 2022-02-28 (Crawled : 13:00) - capgemini.com
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
Judge Approves J&J’s Texas Two-Step Plan to Enable "Expeditious" Compensation
Published: 2022-02-28 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
Sinus Dilation Devices Market size worth $ 3.8 Billion, Globally, by 2028 at 8.32% CAGR: Verified Market Research®
Published: 2022-02-28 (Crawled : 10:00) - prnewswire.com
MDT | $80.265 -1.26% 840K
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
research ces device
Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead of Phase 3 Trial
Published: 2022-02-28 (Crawled : 07:00) - globenewswire.com
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
covid-19 phase 2 trial covid report positive phase 2 results results vaccine phase 3
Janssen is Taking a Big Swing at Autoantibody-Driven Diseases
Published: 2022-02-28 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
disease antibody
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.93 64.96% 55M
|
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
RCAT | $1.52 26.67% 1.3M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.